Qualigen Therapeutics (QLGN) Institutional Ownership $3.47 -0.17 (-4.67%) Closing price 04/25/2025 03:57 PM EasternExtended Trading$3.41 -0.06 (-1.73%) As of 04/25/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Qualigen Therapeutics (NASDAQ:QLGN)CurrentInstitutional OwnershipPercentage3.18%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$27.47KNumber ofInstitutional Sellers(last 12 months)0 Get QLGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Qualigen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QLGN Institutional Buying and Selling by Quarter Qualigen Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025 FNY Investment Advisers LLC7,548$27K0.0%N/A1.026% 8/10/2023Meitav Investment House Ltd.27,293$3.21M0.0%N/A0.540% 7/24/2023Meitav Investment House Ltd.27,293$3.21M0.1%N/A0.540% 5/10/2022Ground Swell Capital LLC43,251$29K0.1%N/A0.123% 1/31/2022Commonwealth Equity Services LLC87,510$93K0.0%-36.4%0.298% 11/15/2021Franklin Resources Inc.82,000$107K0.0%N/A0.283% 11/15/2021GSA Capital Partners LLP78,687$102K0.0%N/A0.271% 10/14/2021Hatton Consulting Inc.27,195$35K0.0%-26.9%0.094% 8/16/2021State Street Corp104,314$208K0.0%N/A0.362% 8/13/2021Renaissance Technologies LLC113,911$227K0.0%N/A0.395% 8/13/2021Geode Capital Management LLC168,702$335K0.0%+10.3%0.585% 8/13/2021Vanguard Group Inc.1,023,911$2.04M0.0%+239.9%3.551% 8/11/2021Commonwealth Equity Services LLC137,510$273K0.0%+10.9%0.477% 8/2/2021Hatton Consulting Inc.37,195$74K0.1%-35.0%0.129% 6/23/2021StoneX Group Inc.13,442$36K0.0%N/A0.047% 5/17/2021Price T Rowe Associates Inc. MD107,500$290K0.0%N/A0.373% 5/12/2021Geode Capital Management LLC152,898$412K0.0%+24.3%0.530% 5/11/2021Vontobel Holding Ltd.25,300$68K0.0%N/A0.088% 5/10/2021GSA Capital Partners LLP18,031$49K0.0%N/A0.063% 5/5/2021Hatton Consulting Inc.57,195$154K0.1%N/A0.198% 5/4/2021Commonwealth Equity Services LLC124,049$334K0.0%+716.3%0.538% 4/28/2021Perkins Capital Management Inc.31,652$85K0.0%N/A0.137% 2/11/2021Northern Trust Corp38,731$117K0.0%N/A0.168% (Data available from 1/1/2016 forward) QLGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QLGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Qualigen Therapeutics shares: Meitav Investment House Ltd. ($3.21M), FNY Investment Advisers LLC ($27K).Learn more on QLGN's institutional investors. What percentage of Qualigen Therapeutics stock is owned by institutional investors? 3.18% of Qualigen Therapeutics stock is owned by institutional investors. Learn more on QLGN's institutional investor holdings. Which institutional investors have been buying Qualigen Therapeutics stock? The following institutional investors have purchased Qualigen Therapeutics stock in the last 24 months: Meitav Investment House Ltd. ($54.59K), and FNY Investment Advisers LLC ($7.55K). How much institutional buying is happening at Qualigen Therapeutics? Institutional investors have bought a total of 62,134 shares in the last 24 months. This purchase volume represents approximately $2.51M in transactions. Related Companies NXTC Institutional Ownership DWTX Institutional Ownership HOTH Institutional Ownership TRIB Institutional Ownership FLGC Institutional Ownership ATHA Institutional Ownership BLRX Institutional Ownership SNSE Institutional Ownership PRTG Institutional Ownership BTAI Institutional Ownership This page (NASDAQ:QLGN) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDeepSeek’s Clear and Present DangerDeepSeek — the alleged “$5.5 million” AI project — isn’t an open-source breakthrough. It’s a Trojan horse.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
